Mutational Patterns in Metastatic Cutaneous Squamous Cell Carcinoma.


Journal

The Journal of investigative dermatology
ISSN: 1523-1747
Titre abrégé: J Invest Dermatol
Pays: United States
ID NLM: 0426720

Informations de publication

Date de publication:
07 2019
Historique:
received: 20 08 2018
revised: 02 01 2019
accepted: 02 01 2019
pubmed: 27 1 2019
medline: 28 5 2020
entrez: 27 1 2019
Statut: ppublish

Résumé

Cutaneous squamous cell carcinoma from the head and neck typically metastasize to the lymph nodes of the neck and parotid glands. When a primary is not identified, they are difficult to distinguish from metastases of mucosal origin and primary salivary gland squamous cell carcinoma. UV radiation causes a mutation pattern that predominantly features cytosine to thymine transitions at dipyrimidine sites and has been associated with cutaneous squamous cell carcinoma. In this study, we used whole genome sequencing data from 15 cutaneous squamous cell carcinoma metastases and show that a UV mutation signature is pervasive across the cohort and distinct from mucosal squamous cell carcinoma. The mutational burden was exceptionally high and concentrated in some regions of the genome, especially insulator elements (mean 162 mutations/megabase). We therefore evaluated the likely impact of UV-induced mutations on the dipyrimidine-rich binding site of the main human insulator protein, CCCTC-binding factor, and the possible implications on CCCTC-binding factor function and the spatial organization of the genome. Our findings suggest that mutation signature analysis may be useful in determining the origin of metastases in the neck and the parotid gland. Furthermore, UV-induced DNA damage to insulator binding sites may play a role in the carcinogenesis and progression of cutaneous squamous cell carcinoma.

Identifiants

pubmed: 30684551
pii: S0022-202X(19)30024-7
doi: 10.1016/j.jid.2019.01.008
pii:
doi:

Substances chimiques

CCCTC-Binding Factor 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1449-1458.e1

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Simon A Mueller (SA)

Sydney Head and Neck Cancer Institute, Chris O'Brien Lifehouse, Sydney, Australia; Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, Australia; Department for Oto-Rhino-Laryngology, Head and Neck Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address: simon.mueller@insel.ch.

Marie-Emilie A Gauthier (MA)

Sydney Head and Neck Cancer Institute, Chris O'Brien Lifehouse, Sydney, Australia; Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, Australia; Children's Cancer Institute, Kensington, Australia.

Bruce Ashford (B)

Sydney Head and Neck Cancer Institute, Chris O'Brien Lifehouse, Sydney, Australia; Illawarra and Shoalhaven Local Health District, Wollongong, Australia; School of Biological Sciences, University of Wollongong, Wollongong, Australia; Illawarra Health and Medical Research Institute, Wollongong, Australia.

Ruta Gupta (R)

Sydney Head and Neck Cancer Institute, Chris O'Brien Lifehouse, Sydney, Australia; Central Clinical School, The University of Sydney, Sydney, Australia; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia.

Velimir Gayevskiy (V)

Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, Australia.

Sydney Ch'ng (S)

Sydney Head and Neck Cancer Institute, Chris O'Brien Lifehouse, Sydney, Australia; Institute of Academic Surgery, University of Sydney, Sydney, Australia; Department of Plastic Surgery, Royal Prince Alfred Hospital, Sydney, Australia.

Carsten E Palme (CE)

Sydney Head and Neck Cancer Institute, Chris O'Brien Lifehouse, Sydney, Australia; Central Clinical School, The University of Sydney, Sydney, Australia.

Kerwin Shannon (K)

Sydney Head and Neck Cancer Institute, Chris O'Brien Lifehouse, Sydney, Australia.

Jonathan R Clark (JR)

Sydney Head and Neck Cancer Institute, Chris O'Brien Lifehouse, Sydney, Australia; Central Clinical School, The University of Sydney, Sydney, Australia; Institute of Academic Surgery, University of Sydney, Sydney, Australia.

Marie Ranson (M)

School of Biological Sciences, University of Wollongong, Wollongong, Australia; Illawarra Health and Medical Research Institute, Wollongong, Australia; Centre for Oncology Education and Research Translation, Liverpool, Australia.

Mark J Cowley (MJ)

Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, Australia; Children's Cancer Institute, Kensington, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH